Clinical Trial Update: BLAZE-Limiting Approach in NMOSD

View source ↗

Summary

This clinical trial update notes the completed status of the BLAZE-Limiting Approach study in neuromyelitis optica spectrum disorders (NMOSD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromyelitis Optica Spectrum Disorders

Snippet

Sponsor: Huashan Hospital | Conditions: Neuromyelitis Optica Spectrum Disorders (NMOSD) | Status: COMPLETED